—

FCPM III SERVICES B.V.

Q1 2026 13F Holdings

  • Location
    naarden, P7
  • Num holdings

    10

  • Value ($000)

    $722,207

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0002013410
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$294.46M
41 %

9,198,900

D
DYN

DYNE THERAPEUTICS INC

COM
26818M108
$84.2M
12 %

4,644,386

---

VOR BIOPHARMA INC

COM NEW
929033207
$73.45M
10 %

4,117,354

E
ENGN

ENGENE HOLDINGS INC

COM
29286M105
$65.6M
9 %

9,632,561

---

MAPLIGHT THERAPEUTICS INC

COM
56565P103
$65.59M
9 %

3,226,400

---

DAMORA THERAPEUTICS INC

COM NEW
36322Q206
$63.22M
9 %

2,441,000

---

CRESCENT BIOPHARMA INC.

COM
G2545C104
$30.82M
4 %

1,677,852

R
REPL

REPLIMUNE GROUP INC

COM
76029N106
$21.48M
3 %

2,808,368

B
BCYC

BICYCLE THERAPEUTICS PLC

SPONSORED ADS
088786108
$16.09M
2 %

3,468,430

E
ENGNW

ENGENE HOLDINGS INC

W EXP 10/31/2028
29286M113
$7.28M
1 %

2,878,148

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 10